About Marianna Limas

This author has not yet filled in any details.
So far Marianna Limas has created 160 blog entries.

Synpromics Granted Key Patent in Synthetic Promoter Development

Edinburgh, UK, 16th March 2017 / Sciad Newswire / Synpromics Ltd, the leading synthetic promoter and gene control company, is pleased to announce it has been granted a key patent (EP2668277B1) by the European Patent Office, protecting PromPT™ - its proprietary synthetic [...]

By | March 16th, 2017|DNA Synthesis, Industry Providers, News, Press Releases|

Eurofins Genomics US Announces Commercial Launch of Next Generation DNA Synthesis Service

LOUISVILLE, Ky., March 14, 2017 /PRNewswire/ -- Eurofins Genomics, the pioneer of high-throughput oligonucleotide synthesis, announced the U.S. commercial launch of a unique DNA synthesis service based on the company's revolutionary next-generation synthesis platform. The service, which is designed to [...]

By | March 16th, 2017|DNA Synthesis, Industry Providers, News, Press Releases|

BioBright Tools Bring ‘Superpowers’ to the Biology Lab

March 14, 2017 09:00 AM Eastern Daylight Time  BOSTON--(BUSINESS WIRE)--BioBright, a firm developing technologies to enable more precise, more reproducible research protocols in biology, has improved the accuracy of a delicate laboratory technique by more than 20 times in the [...]

Allergan and Editas Medicine Enter into Strategic R&D Alliance to Discover and Develop CRISPR Genome Editing Medicines for Eye Diseases

DUBLIN, Ireland and CAMBRIDGE, Mass., March 14, 2017 (GLOBE NEWSWIRE) -- Allergan plc (NYSE:AGN), a leading global pharmaceutical company, and Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today announced that Allergan’s wholly-owned subsidiary, Allergan Pharmaceuticals International Limited, and [...]

By | March 14th, 2017|BioPharma & Healthcare, News, Press Releases, Therapeutics|

CRISPR Therapeutics and Casebia Therapeutics Announce Commercial License Agreement With MaxCyte

BASEL, Switzerland, CAMBRIDGE, Mass., and GAITHERSBURG, Md., March 14, 2017 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, and Casebia Therapeutics, a joint-venture established by CRISPR Therapeutics and Bayer AG [...]

By | March 14th, 2017|News, Press Releases|

Intrexon Creates Precigen, Inc. and Accelerates Strategic Review of Structural Options Related to Health Assets

GERMANTOWN, Md., March 10, 2017 /PRNewswire/ -- Intrexon Corporation (NYSE: XON), a leader in the engineering and industrialization of biology to improve the quality of life and health of the planet, today announced the formation of Precigen, Inc., a wholly-owned [...]

By | March 14th, 2017|BioPharma & Healthcare, News, Press Releases, Therapeutics|